Media LibraryContact Us
Products Corporate Tissue Services
Search
LifeCell's Technology
Research & Development
Investor Information
Career Opportunities
Regulatory Licensing Documentation
Quality Policy

Governance

LifeCell's patented human tissue matrix, Alloderm®, has been successfully used in over 1 million grafts and implants to date, and a growing body of clinical evidence points to its potential use in a host of other surgical applications.

Committees of the Board of Directors

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee is empowered by the Board of Directors to, among other functions: identify qualified individuals for membership on the Board; recommend to the board the director nominees for election at the next annual meeting of stockholders; make recommendations to the Board regarding the size and composition of the Board and its committees; monitor the effectiveness of the Board; and develop and implement corporate governance principles and policies.

Audit Committee

The Audit Committee is empowered by the Board of Directors to, among other functions: serve as an independent and objective party to monitor the Company's financial reporting process, internal control system and disclosure control system; review and appraise the audit efforts of the Company's independent registered public accountants; assume direct responsibility for the appointment, compensation, retention and oversight of the work of the independent accountants and for the resolution of disputes between the independent accountants and the Company's management regarding financial reporting issues; and provide an open avenue of communication among the independent accountants, financial and senior management and the Board.


Compensation Committee

The Compensation Committee is empowered by the Board of Directors to, among other functions: assist the Board in carrying out their responsibilities relating to compensation of the Company’s directors and officers. The Compensation Committee has overall responsibility for evaluating and approving the Company’s director and officer compensation plans, policies and programs.